Back to User profile » Dr Michelle K White

Papers published by Dr Michelle K White:

Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group

Rizio AA, White MK, D’Souza A, Hsu K, Schmitt P, Quock TP, Signorovitch J, Lousada I, Sanchorawala V

Patient Related Outcome Measures 2023, 14:153-169

Published Date: 18 May 2023

Work Outcomes Among Patients with Light Chain (AL) Amyloidosis: Findings from Three Patient Cohorts

Rizio AA, McCausland KL, White MK, Quock TP

Patient Related Outcome Measures 2021, 12:339-347

Published Date: 15 December 2021

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder

Lam RW, Lamy FX, Danchenko N, Yarlas A, White MK, Rive B, Saragoussi D

Neuropsychiatric Disease and Treatment 2018, 14:2861-2877

Published Date: 29 October 2018

Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples

White MK, McCausland KL, Sanchorawala V, Guthrie SD, Bayliss MS

Patient Related Outcome Measures 2017, 8:157-167

Published Date: 7 December 2017